Having a gentle flavor and small crunch, they may be eaten raw in salads or topping sandwiches or prepared to improve the flavor of many popular dishes. Packed with nutrition and antioxidants and offering protection from cancer, broccoli sprouts certainly are a perfect veggie to include in a healthy lifestyle.. Bristol-Myers Squibb reports results from brivanib plus sorafenib stage III trial on HCC Bristol-Myers Squibb Organization today reported the result of the phase III BRISK-FL scientific trial of the investigational agent brivanib versus sorafenib as first-series treatment in sufferers with advanced hepatocellular carcinoma .Protect from heat, light and moisture. Keep out of reach of kids.. Clovis Oncology reports net lack of $15.7 million for second quarter 2012 Clovis Oncology, Inc. today reported financial results for the second quarter 2012, and provided an revise on the progress of its clinical development programs and expected milestones for all of those other year. Mahaffy, CEO and President of Clovis Oncology. We would like to expand our pipeline through our collaboration with Array BioPharma for the discovery of a novel mutant KIT inhibitor; each of our three current clinical programs continues to advance, & most importantly, we stick to monitor to announce the results from our pivotal LEAP trial of CO-101 in metastatic pancreatic cancer through the fourth quarter this full year. 2012 Financial Results and Outlook Clovis reported a net loss of $15.7 million for the next quarter of 2012, and $34.7 million for the first half of 2012.